Dong Tian1, Yu Wang2, Haruhiko Shiiya3, Chang-Bo Sun4, Yukari Uemura5, Masaaki Sato6, Jun Nakajima4. 1. Department of Thoracic Surgery, Graduate School of Medicine, University of Tokyo Hospital, Tokyo, Japan; Department of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China. 2. Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China. 3. Department of Thoracic Surgery, Graduate School of Medicine, University of Tokyo Hospital, Tokyo, Japan; Department of Cardiovascular and Thoracic Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan. 4. Department of Thoracic Surgery, Graduate School of Medicine, University of Tokyo Hospital, Tokyo, Japan. 5. Biostatistics Division, Clinical Research Support Center, University of Tokyo Hospital, Tokyo, Japan. 6. Department of Thoracic Surgery, Graduate School of Medicine, University of Tokyo Hospital, Tokyo, Japan. Electronic address: satom-sur@h.u-tokyo.ac.jp.
Abstract
OBJECTIVE: Ex vivo lung perfusion (EVLP) is reportedly a useful strategy that permits marginal donor lungs to be evaluated and reconditioned for successful lung transplantation (LTx). This systematic review and meta-analysis was performed to evaluate the outcomes of EVLP conducted for marginal donor lungs. METHODS: We searched PubMed, the Cochrane Library, and Embase to select studies describing the results of LTx following EVLP for marginal donor lungs compared with standard LTx without EVLP. We performed a meta-analysis to examine donor baseline characteristics, recipient baseline characteristics, and postoperative outcomes. RESULTS: Of 1380 studies, 8 studies involving 1191 patients met the inclusion criteria. Compared with the non-EVLP group (ie, standard LTx without EVLP), the EVLP group (ie, EVLP of marginal donors following LTx) had similar donor age and sex and recipient baseline age, sex, body mass index, bridge by ventilator/extracorporeal life support/extracorporeal membrane oxygenation, and rate of double LTx but more abnormal donor lung radiographs (P = .0002), a higher smoking history rate (P = .03), and worse donor arterial oxygen tension/inspired oxygen fraction (P < .00001). However, there were no significant differences in outcomes between the EVLP and non-EVLP groups with respect to the length of postoperative intubation, postoperative extracorporeal life support/extracorporeal membrane oxygenation use, length of intensive care unit stay, length of hospital stay, 72-hour primary graft dysfunction of grade 3, 30-day survival, or 1-year survival (all P values > .05). CONCLUSIONS: Posttransplant outcomes were similar between EVLP-treated LTx and standard LTx without EVLP, although the quality of donor lungs was worse with EVLP-treated LTx.
OBJECTIVE: Ex vivo lung perfusion (EVLP) is reportedly a useful strategy that permits marginal donor lungs to be evaluated and reconditioned for successful lung transplantation (LTx). This systematic review and meta-analysis was performed to evaluate the outcomes of EVLP conducted for marginal donor lungs. METHODS: We searched PubMed, the Cochrane Library, and Embase to select studies describing the results of LTx following EVLP for marginal donor lungs compared with standard LTx without EVLP. We performed a meta-analysis to examine donor baseline characteristics, recipient baseline characteristics, and postoperative outcomes. RESULTS: Of 1380 studies, 8 studies involving 1191 patients met the inclusion criteria. Compared with the non-EVLP group (ie, standard LTx without EVLP), the EVLP group (ie, EVLP of marginal donors following LTx) had similar donor age and sex and recipient baseline age, sex, body mass index, bridge by ventilator/extracorporeal life support/extracorporeal membrane oxygenation, and rate of double LTx but more abnormal donor lung radiographs (P = .0002), a higher smoking history rate (P = .03), and worse donor arterial oxygen tension/inspired oxygen fraction (P < .00001). However, there were no significant differences in outcomes between the EVLP and non-EVLP groups with respect to the length of postoperative intubation, postoperative extracorporeal life support/extracorporeal membrane oxygenation use, length of intensive care unit stay, length of hospital stay, 72-hour primary graft dysfunction of grade 3, 30-day survival, or 1-year survival (all P values > .05). CONCLUSIONS: Posttransplant outcomes were similar between EVLP-treated LTx and standard LTx without EVLP, although the quality of donor lungs was worse with EVLP-treated LTx.
Authors: Samantha E Halpern; Samuel J Kesseli; Sandra Au; Madison K Krischak; Danae G Olaso; Haley Smith; Greg Tipton; Ian R Jamieson; Andrew S Barbas; John C Haney; Jacob A Klapper; Matthew G Hartwig Journal: Am J Transplant Date: 2021-09-02 Impact factor: 8.086
Authors: Danielle M Peterson; Eliza W Beal; Brenda F Reader; Curtis Dumond; Sylvester M Black; Bryan A Whitson Journal: ASAIO J Date: 2022-01-20 Impact factor: 3.826
Authors: Andy Chao Hsuan Lee; Arianna Edobor; Thirushan Wigakumar; Maria Lysandrou; Laura K Johnston; Phillip McMullen; Vikranth Mirle; Ashley Diaz; Ryan Piech; Rebecca Rose; Martin Jendrisak; Diego di Sabato; Kumaran Shanmugarajah; John Fung; Jessica Donington; Maria Lucia Madariaga Journal: Clin Transplant Date: 2022-04-18 Impact factor: 3.456